A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer?strains 16 and 18.
Taking iron during pregnancy has been recommended in the past as a preventive treatment to help promote fetal and placental growth.
Pfizer Inc announced that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has recommended Champix (varenicline) for use on the National Health Service for adult smokers who have expressed a desire to quit.
GlaxoSmithKline (GSK) confirms that a letter to the editor summarising additional Avandia cardiovascular safety data from several large-scale clinical trials was published online today in The Lancet.
Patients with severe heart disease may soon have access to a simple injection to help manage their symptoms and reduce their need for large amounts of pain relief medication if a groundbreaking new study at the Victor Chang Cardiac Research Institute is successful.
New research from Newcastle University shows treatment for a shortage of the hormone thyroxine lowers cholesterol, reverses weight gain and reduces the risk factors for heart disease.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the U.S. Food and Drug Administration (FDA) has approved the oral contraceptive Lybrel? (90 mcg levonorgestrel/20 mcg ethinyl estradiol) tablets for the prevention of pregnancy in women who elect to use oral contraceptives and who have no known contraindications for this method of contraception.
A new study presented showed that ramelteon did not impair middle-of-the-night balance, mobility or memory performance in older adults with insomnia, relative to placebo.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox, an investigational treatment for adult patients diagnosed with schizophrenia, today at the 2007 annual meeting of the American Psychiatric Association.
A new study presented showed that ramelteon did not impair middle-of-the-night balance, mobility or memory performance in older adults with insomnia, relative to placebo.